China Traditional Chinese Medicine Holdings Co. Limited (CHIZF)
OTCMKTS · Delayed Price · Currency is USD
0.2734
-0.0720 (-20.85%)
At close: Sep 30, 2025
CHIZF Revenue
China Traditional Chinese Medicine Holdings Co. had revenue of 7.46B CNY in the half year ending June 30, 2025, a decrease of -19.77%. This brings the company's revenue in the last twelve months to 15.59B, down -9.40% year-over-year. In the year 2024, China Traditional Chinese Medicine Holdings Co. had annual revenue of 16.51B, down -8.90%.
Revenue (ttm)
15.59B CNY
Revenue Growth
-9.40%
P/S Ratio
0.60
Revenue / Employee
1.00M CNY
Employees
15,583
Market Cap
1.31B USD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 16.51B | -1.61B | -8.90% |
| Dec 31, 2023 | 18.12B | 3.82B | 26.69% |
| Dec 31, 2022 | 14.30B | -4.75B | -24.92% |
| Dec 31, 2021 | 19.05B | 4.25B | 28.68% |
| Dec 31, 2020 | 14.81B | 485.22M | 3.39% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Sofgen Pharma | 423.75M |
| Jushi Holdings | 260.43M |
| Glass House Brands | 196.17M |
| MariMed | 157.38M |
| Elite Pharmaceuticals | 122.89M |
| Earth Science Tech | 33.84M |
| Radnostix | 14.07M |
| Healthy Extracts | 3.59M |